298 related articles for article (PubMed ID: 21538175)
21. Low brain ascorbic acid increases susceptibility to seizures in mouse models of decreased brain ascorbic acid transport and Alzheimer's disease.
Warner TA; Kang JQ; Kennard JA; Harrison FE
Epilepsy Res; 2015 Feb; 110():20-5. PubMed ID: 25616451
[TBL] [Abstract][Full Text] [Related]
22. Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice.
Harrison FE; Allard J; Bixler R; Usoh C; Li L; May JM; McDonald MP
Nutr Neurosci; 2009 Oct; 12(5):203-18. PubMed ID: 19761651
[TBL] [Abstract][Full Text] [Related]
23. Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels.
Ruiz HH; Chi T; Shin AC; Lindtner C; Hsieh W; Ehrlich M; Gandy S; Buettner C
Alzheimers Dement; 2016 Aug; 12(8):851-61. PubMed ID: 26928090
[TBL] [Abstract][Full Text] [Related]
24. High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease.
Taheri S; Yu J; Zhu H; Kindy MS
J Alzheimers Dis; 2016 Oct; 54(3):1061-1072. PubMed ID: 27567835
[TBL] [Abstract][Full Text] [Related]
25. Differential proteomic and behavioral effects of long-term voluntary exercise in wild-type and APP-overexpressing transgenics.
Rao SK; Ross JM; Harrison FE; Bernardo A; Reiserer RS; Reiserer RS; Mobley JA; McDonald MP
Neurobiol Dis; 2015 Jun; 78():45-55. PubMed ID: 25818006
[TBL] [Abstract][Full Text] [Related]
26. Hippocampal neurobiology and function in an aged mouse model of TDP-43 proteinopathy in an APP/PSEN1 background.
Arezoumandan S; Cai X; Kalkarni P; Davis SA; Wilson K; Ferris CF; Cairns NJ; Gitcho MA
Neurosci Lett; 2021 Jul; 758():136010. PubMed ID: 34090937
[TBL] [Abstract][Full Text] [Related]
27. PSEN1 promoter demethylation in hyperhomocysteinemic TgCRND8 mice is the culprit, not the consequence.
Fuso A; Cavallaro RA; Nicolia V; Scarpa S
Curr Alzheimer Res; 2012 Jun; 9(5):527-35. PubMed ID: 22272624
[TBL] [Abstract][Full Text] [Related]
28. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
29. APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding.
Czeczor JK; Genders AJ; Aston-Mourney K; Connor T; Hall LG; Hasebe K; Ellis M; De Jong KA; Henstridge DC; Meikle PJ; Febbraio MA; Walder K; McGee SL
J Endocrinol; 2018 Jun; 237(3):311-322. PubMed ID: 29674342
[TBL] [Abstract][Full Text] [Related]
30. The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.
Puig KL; Kulas JA; Franklin W; Rakoczy SG; Taglialatela G; Brown-Borg HM; Combs CK
Neurobiol Aging; 2016 Apr; 40():22-40. PubMed ID: 26973101
[TBL] [Abstract][Full Text] [Related]
31. Effects of hepatic protein tyrosine phosphatase 1B and methionine restriction on hepatic and whole-body glucose and lipid metabolism in mice.
Lees EK; Krol E; Shearer K; Mody N; Gettys TW; Delibegovic M
Metabolism; 2015 Feb; 64(2):305-14. PubMed ID: 25468142
[TBL] [Abstract][Full Text] [Related]
32. High fat diet worsens Alzheimer's disease-related behavioral abnormalities and neuropathology in APP/PS1 mice, but not by synergistically decreasing cerebral blood flow.
Bracko O; Vinarcsik LK; Cruz Hernández JC; Ruiz-Uribe NE; Haft-Javaherian M; Falkenhain K; Ramanauskaite EM; Ali M; Mohapatra A; Swallow MA; Njiru BN; Muse V; Michelucci PE; Nishimura N; Schaffer CB
Sci Rep; 2020 Jun; 10(1):9884. PubMed ID: 32555372
[TBL] [Abstract][Full Text] [Related]
33. Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer's disease.
Zhang Y; Yin F; Liu J; Liu Z; Guo L; Xia Z; Zidichouski J
Neurochem Int; 2015 Oct; 89():7-16. PubMed ID: 25882165
[TBL] [Abstract][Full Text] [Related]
34. The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease.
Kim B; Elzinga SE; Henn RE; McGinley LM; Feldman EL
Neurobiol Dis; 2019 Dec; 132():104541. PubMed ID: 31349033
[TBL] [Abstract][Full Text] [Related]
35. BACE cleavage of APP does not drive the diabetic phenotype of PLB4 mice.
Franklin ZJ; Croce L; Dekeryte R; Delibegovic M; Platt B
Neurobiol Dis; 2023 Jun; 182():106142. PubMed ID: 37137417
[TBL] [Abstract][Full Text] [Related]
36. Beta-secretase/BACE1 promotes APP endocytosis and processing in the endosomes and on cell membrane.
Wang M; Jing T; Wang X; Yao D
Neurosci Lett; 2018 Oct; 685():63-67. PubMed ID: 30120949
[TBL] [Abstract][Full Text] [Related]
37. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease.
Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B
Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948
[TBL] [Abstract][Full Text] [Related]
38. Effective expression of Drebrin in hippocampus improves cognitive function and alleviates lesions of Alzheimer's disease in APP (swe)/PS1 (ΔE9) mice.
Liu Y; Xu YF; Zhang L; Huang L; Yu P; Zhu H; Deng W; Qin C
CNS Neurosci Ther; 2017 Jul; 23(7):590-604. PubMed ID: 28597477
[TBL] [Abstract][Full Text] [Related]
39. Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage.
Zhang C; Browne A; Kim DY; Tanzi RE
Curr Alzheimer Res; 2010 Feb; 7(1):21-6. PubMed ID: 20205669
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.
Ettcheto M; Cano A; Manzine PR; Busquets O; Verdaguer E; Castro-Torres RD; García ML; Beas-Zarate C; Olloquequi J; Auladell C; Folch J; Camins A
Mol Neurobiol; 2020 Apr; 57(4):1814-1827. PubMed ID: 31838720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
